• Peripheral Macrophages Drive Pain Priming in Sleep Apnea Mod

  2026-07-28

  Chivers et al. reveal that peripheral macrophage infiltration underpins nociceptor priming and persistent pain in a mouse model of chronic intermittent hypoxia, effectively modeling obstructive sleep apnea. These findings illuminate immune mechanisms linking sleep-disordered breathing to chronic pain, offering new therapeutic targets.

• Tristetraprolin-Mediated m6A Regulation Attenuates Liver Fib

  2026-07-28

  This study uncovers a novel anti-fibrotic mechanism in schistosomiasis-induced liver fibrosis, revealing that tristetraprolin (TTP) suppresses hepatic stellate cell activation via m6A-mediated destabilization of TGF-β1 mRNA. These insights highlight the therapeutic potential of targeting the WTAP/m6A axis for epigenetic intervention in hepatic fibrotic diseases.

• N-MYC/eIF4G1 Axis Controls Survival in inv(16) AML: New Mech

  2026-07-27

  This study uncovers a pivotal role for N-MYC and its downstream target eIF4G1 in supporting the survival of inv(16) acute myeloid leukemia (AML) cells. By mapping the transcriptional consequences of CBFβ-SMMHC inhibition, the research identifies critical regulatory mechanisms and provides rationale for targeting the N-MYC/eIF4G1 axis in myeloid leukemia.

• Amikacin Sulfate (SKU C8696): Optimizing Intracellular Antib

  2026-07-27

  This article addresses key challenges in cell-based infection models, focusing on reproducibility, intracellular delivery, and cytotoxicity when using Amikacin Sulfate (SKU C8696). Scenario-driven Q&A blocks illustrate how this aminoglycoside supports sensitive, reliable workflows in modern mycobacterial and staphylococcal research. Evidence-based recommendations and protocol parameters are provided for biomedical scientists seeking robust experimental outcomes.

• 3-Deazaadenosine: Advanced S-adenosylhomocysteine Hydrolase

  2026-07-26

  3-Deazaadenosine empowers researchers to dissect methylation-dependent pathways and preclinical antiviral models with unmatched precision. This article delivers actionable protocols, advanced troubleshooting, and novel experimental insights, including strategies inspired by m6A-mediated liver fibrosis regulation.

• Z-LEHD-FMK: Shaping Apoptosis Research and Translational Imp

  2026-07-25

  This thought-leadership article explores the mechanistic importance of caspase-9 in mitochondria-mediated apoptosis and how APExBIO’s Z-LEHD-FMK, an irreversible caspase-9 inhibitor, enables translational researchers to dissect cell death pathways with unprecedented precision. Integrating recent findings on graphene-induced apoptosis in melanoma, we discuss evidence-backed workflows, competitive positioning, and future directions for leveraging caspase-9 inhibition in neuroprotection and cancer research.

• 2-NBDG Applied: Precision Glucose Uptake Assays in Disease M

  2026-07-24

  2-NBDG, or 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose, enables rapid, quantitative analysis of cellular glucose uptake by leveraging its unique fluorescence properties. This article details stepwise protocols, advanced troubleshooting, and strategic use-cases—bridging recent metabolic insights from diabetes research to real-world workflow optimization.

• Streamlining Mouse Genotyping: Mechanism, Strategy, and Impa

  2026-07-24

  This thought-leadership article explores how advances in direct, purification-free mouse genotyping—epitomized by the Direct Mouse Genotyping Kit Plus—are reshaping translational research. We bridge mechanistic insight, experimental rigor, and workflow acceleration, highlighting strategic value for gene editing, transgenic validation, and disease modeling. Integrating new evidence from SCA3/MJD neurodegeneration studies, we discuss the future of precision colony screening and its translational promise.

• Nullscript: Precision Histone Deacetylase Inhibitor for Card

  2026-07-23

  Nullscript empowers researchers to dissect histone deacetylase (HDAC) function with unprecedented selectivity—reducing confounding transcriptional effects while delivering robust in vivo performance, notably in cardiac ischemia/reperfusion models. Learn how to optimize workflows, troubleshoot pitfalls, and leverage Nullscript’s unique inactivity in transcriptional facilitation for translational breakthroughs.

• Zosuquidar (LY335979): Enhancing Cancer MDR Reversal Workflo

  2026-07-23

  Zosuquidar (LY335979) 3HCl offers precise, potent inhibition of P-glycoprotein to restore chemotherapeutic sensitivity in multidrug-resistant cancer models. This guide delivers actionable workflow enhancements, troubleshooting insights, and translational best practices to maximize the impact of Zosuquidar in both in vitro and in vivo research.

• DiR (DiIC 18 (7)): Defining the Gold Standard for Long-Term

  2026-07-22

  Explore how DiR (DiIC 18 (7)) sets a new benchmark in long-term, high-sensitivity membrane and extracellular vesicle (EV) tracking. This comprehensive analysis reveals unique protocol insights and practical assay considerations for advanced cell and tissue imaging.

• AT1 Blockade and Gastrodin Modulate Astrocyte Reactivity via

  2026-07-22

  This study uncovers how gastrodin and selective AT1 receptor inhibition regulate the renin-angiotensin system–SIRT3 axis and inflammation in reactive astrocytes, mediated by microglial signaling. The findings provide mechanistic insight and experimental guidance for research into neuroinflammation and CNS homeostasis.

• Fasudil (HA-1077) HCl: Optimizing ROCK Inhibition in Cancer

  2026-07-21

  Fasudil (HA-1077) HCl empowers researchers to dissect the Rho/ROCK pathway with unmatched precision, supporting robust control over cell migration, proliferation, and apoptosis in both in vitro and in vivo cancer models. Its distinct selectivity and solubility properties streamline protocol development, while innovative workflows inspired by recent pathway crosstalk studies unlock new frontiers in cell signaling research.

• Sodium Ascorbate in Cancer Research: Workflow and Optimizati

  2026-07-21

  Sodium Ascorbate, a mineral salt of ascorbic acid, enables precise modulation of intracellular ROS and necrotic tumor cell death, making it indispensable for glioblastoma multiforme and broader cancer research. This guide details protocol enhancements, troubleshooting, and workflow integration for maximizing reproducibility and selective cytotoxicity with APExBIO’s high-purity Sodium Ascorbate.

• RNA Clean and Concentrator Kit: Streamlining RNA Purificatio

  2026-07-20

  The RNA Clean and Concentrator Kit delivers high-throughput, high-fidelity RNA purification from complex enzymatic reactions, supporting advanced workflows such as mRNA-LNP therapeutics and in vitro transcription. Its spin column design accelerates cleanup and ensures reproducible, contaminant-free RNA, enabling translational breakthroughs in molecular biology.

15969 records 1/1065 page Next 12345 下5页 Last page